Open AccessPerceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey
Author(s) -
Elissar Moujaess,
Naji Bou Zeid,
Ramy Samaha,
Joud Sawan,
Hampig Raphaël Kourié,
Chris Labaki,
Roy Chebel,
Georges Chahine,
Fadi El Karak,
Fadi Nasr,
Marwan Ghosn,
Jad Wakim,
Joseph Kattan
Publication year - 2021
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2021-0265
Subject(s) - medicine , family medicine , vaccination , cancer , population , disease , covid-19 , immunology , environmental health , infectious disease (medical specialty)
Aims: This paper reports the results of a survey assessing the acceptance of the COVID-19 vaccine among patients with cancer. Patients and methods: In total, 111 adult patients with cancer from a single institution were asked to complete a questionnaire designed to assess their knowledge about the vaccine, their readiness to be vaccinated and the determinants of their decision. Results: 61.3% of the patients considered themselves more vulnerable to COVID-19 than the general population. Television, radio and newspapers were the major sources of information about the vaccine. A total of 55% of the patients were ready to be vaccinated and 14.4% refused the vaccine. The main reason for refusal was incompatibility with patients' disease or treatment. Conclusion: Most of the patients in this institutional sample accepted the COVID-19 vaccine. Better communication of information with patients is needed to decrease vaccine hesitancy.